HIV serostatus disclosure and associated factors among HIV positive pregnant and lactating women at Nekemte public health facilities, western Ethiopia.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
05
09
2020
accepted:
23
02
2021
entrez:
19
3
2021
pubmed:
20
3
2021
medline:
12
10
2021
Statut:
epublish
Résumé
Disclosure of Human Immune Virus (HIV) serostatus by pregnant and lactating women is crucial for the successful prevention of mother to child transmission of HIV/AIDS. However, little has been studied regarding the prevalence and factors associated with HIV status disclosure among HIV positive pregnant and lactating women in Ethiopia. An institution-based cross-sectional study was conducted in the Nekemte Public Health facilities among 380 pregnant and lactating women enrolled in universal antiretroviral therapy (ART) treatment from January 2015-December, 2019. The data were collected by using a checklist, developed from Prevention of Mother to Child Transmission (PMTCT) logbook, ART intake forms, and medical cards of the patients. Epidata version 3.2 was used for data entry, and then the data were exported to STATA version 14 for further analysis. The binary logistic regression model was employed to determine factors associated with the disclosure status among HIV positive pregnant and lactating women. Adjusted Odds Ratio (AOR) with 95% confidence intervals was computed and statistical significance was declared when it is significant at a 5% level (p-value < 0.05). A total of 380 women have participated in the study. Two hundred seventy-six (73.4%) of women had disclosed their HIV status to at least one individual. The study found living in urban (OR = 1.83, 95% CI: 1.04, 3.20), married women (OR = 4.16, 95% CI: 1.87, 9.24), higher educational status (OR = 2.35, 95% CI: 1.31, 5.51), positive HIV status of partner (OR = 2.35, 95%CI: 1.17, 4.70), and being multipara (OR = 4.94, 95% CI: 2.29, 10.66) were independent determinants of HIV status disclosure. HIV status disclosure among pregnant and lactating women in the study area was sub-optimal. Empowering women through education, encouraging partners for HIV testing, and enhancing active male involvement in HIV treatment and control programs should get due attention.
Sections du résumé
BACKGROUND
Disclosure of Human Immune Virus (HIV) serostatus by pregnant and lactating women is crucial for the successful prevention of mother to child transmission of HIV/AIDS. However, little has been studied regarding the prevalence and factors associated with HIV status disclosure among HIV positive pregnant and lactating women in Ethiopia.
METHODS
An institution-based cross-sectional study was conducted in the Nekemte Public Health facilities among 380 pregnant and lactating women enrolled in universal antiretroviral therapy (ART) treatment from January 2015-December, 2019. The data were collected by using a checklist, developed from Prevention of Mother to Child Transmission (PMTCT) logbook, ART intake forms, and medical cards of the patients. Epidata version 3.2 was used for data entry, and then the data were exported to STATA version 14 for further analysis. The binary logistic regression model was employed to determine factors associated with the disclosure status among HIV positive pregnant and lactating women. Adjusted Odds Ratio (AOR) with 95% confidence intervals was computed and statistical significance was declared when it is significant at a 5% level (p-value < 0.05).
RESULTS
A total of 380 women have participated in the study. Two hundred seventy-six (73.4%) of women had disclosed their HIV status to at least one individual. The study found living in urban (OR = 1.83, 95% CI: 1.04, 3.20), married women (OR = 4.16, 95% CI: 1.87, 9.24), higher educational status (OR = 2.35, 95% CI: 1.31, 5.51), positive HIV status of partner (OR = 2.35, 95%CI: 1.17, 4.70), and being multipara (OR = 4.94, 95% CI: 2.29, 10.66) were independent determinants of HIV status disclosure.
CONCLUSIONS
HIV status disclosure among pregnant and lactating women in the study area was sub-optimal. Empowering women through education, encouraging partners for HIV testing, and enhancing active male involvement in HIV treatment and control programs should get due attention.
Identifiants
pubmed: 33739992
doi: 10.1371/journal.pone.0248278
pii: PONE-D-20-27995
pmc: PMC7978369
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0248278Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
BMC Public Health. 2008 Feb 29;8:81
pubmed: 18312653
AIDS Res Treat. 2019 Aug 01;2019:3862098
pubmed: 31467708
Pan Afr Med J. 2019 Apr 24;32:200
pubmed: 31312312
PLoS One. 2019 Mar 13;14(3):e0211921
pubmed: 30865633
AIDS Care. 2015;27(4):436-50
pubmed: 25636060
PLoS One. 2014 Oct 28;9(10):e109447
pubmed: 25350001
AIDS Behav. 2017 Jul;21(Suppl 1):23-33
pubmed: 28063074
BMC Public Health. 2013 Aug 17;13:765
pubmed: 23957627
AIDS Care. 2012;24(1):46-53
pubmed: 21767226
BMC Public Health. 2019 Dec 27;19(1):1743
pubmed: 31881867
AIDS Care. 2008 Nov;20(10):1266-75
pubmed: 18608080
AIDS Behav. 2018 Dec;22(12):3933-3944
pubmed: 30155586
AIDS. 2015 Jun;29 Suppl 1:S7-S23
pubmed: 26049541
Pan Afr Med J. 2020 Sep 15;37:58
pubmed: 33209185
AIDS Behav. 2005 Mar;9(1):15-26
pubmed: 15812610
East Afr J Public Health. 2010 Mar;7(1):87-91
pubmed: 21413581
Sante Publique. 2018 Aug 21;30(3):397-403
pubmed: 30541269
AIDS Care. 2021 Aug;33(8):1009-1015
pubmed: 32741204
BMC Public Health. 2014 Jul 23;14:746
pubmed: 25056689
Reprod Health. 2017 Aug 30;14(1):107
pubmed: 28854944